Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2001
09/25/2001US6294663 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
09/25/2001US6294662 Nucleic acids encoding an endometrial bleeding associated factor (ebaf)
09/25/2001US6294661 Compounds
09/25/2001US6294653 RNA binding protein and binding site useful for expression of recombinant molecules
09/25/2001US6294652 Response regulator
09/25/2001US6294530 Heterocyclic compounds for nervous system disorders
09/25/2001US6294392 Spatially-encoded analyte detection
09/25/2001US6294391 Using solid support having analog of analyte of interest and binding partner reversibly bound to analog, displacing binding partner from support in response to presence of analyte causing detectable reduction in mass of solid support
09/25/2001US6294390 Compound consisting of ionophore, fluorophore, and a functional group bound together through a trivalent organic radical; sensors having long usable life and a high degree of sensitivity
09/25/2001US6294388 Indirect calibration of polymer characterization systems
09/25/2001US6294385 Efficient random or quasi-random process by introducing into target cell a complex of transposase protein and polynucleotide; polynucleotide has nucleotide sequences which interact with enzyme and a transposable nucleotide sequence
09/25/2001US6294383 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
09/25/2001US6294381 Enriching for cd11c negative dendritic cells by contacting with anti-cd123 antibody, then selecting positive cells
09/25/2001US6294363 Rapid method of proteasome purification using proteins having sequence homology to ubiquitin
09/25/2001US6294355 Polynucleotide encoding polypeptide of defined amino acid seuqence; diagnosis; drug screening; antiepileptic agents; treatment of nervous system disorders; treatment of drug abuse, drug dependence
09/25/2001US6294352 Nucleotide sequence which code polypeptide which binds tumor necrosis factor; for the reduction of side effects associated with tumor necrosis factor treatments
09/25/2001US6294350 Methods for treating fibroproliferative diseases
09/25/2001US6294349 Method of diagnosing and monitoring malignant breast carcinomas
09/25/2001US6294348 Detection of moduators of signal transduction; incubate sample with modulator and monitor sample for adjustment in signal transduction
09/25/2001US6294347 Human FCγ receptor III
09/25/2001US6294346 Preparing cell culture of neurospheres comprising cluster of neural stem cells, contacting with agent, and determining effect on proliferation, differentiation or survival; treatment of nervous system disorders
09/25/2001US6294344 Detecting tumor of urogenetial system in humans; obtain sample of human tissue, detect chymotrypsin enzyme in sample, the presence of amplified expression of chymotrypsin is indictive of tumor
09/25/2001US6294343 Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/25/2001US6294342 Apparatus for the accurate measurement of preferential particles in sample
09/25/2001US6294341 Process for detecting glutathione s-transferase bound thioredoxin; adsorb thioredoxin on surface of culture vessel, mix glutathione s-transferase, mix antibody, mix peroxide and o-phenylenediamine, detect color development
09/25/2001US6294340 Method of binding material to the β-amyloid peptide
09/25/2001US6294338 Polynucleotide amplification method
09/25/2001US6294335 Method of diagnosing abnormal cell growth
09/25/2001US6294333 Fluorescent intensity assay for protein or peptide binding to nucleic acids
09/25/2001US6294330 Screening ligands of cellular receptor by generating vectors encoding fusion proteins of fragments of reporter molecule and subdomains of receptor, transfecting cells with vectors, testing cells for reporter molecule activity
09/25/2001US6294327 Scanning device for imaging nucleotide sequences in sample
09/25/2001US6294324 Processing for attaching an end of a nucleic acid to a surface by utilizing pH
09/25/2001US6294321 Simple method by contacting sample with beta-(1-3)-glucan binding agent to form complexes, then detecting complexes as indication of infection
09/25/2001US6294320 Cell matrix plaques of initial bone formation
09/25/2001US6294177 Particularly useful in the treatment of mastitis.
09/25/2001US6294174 Peptides immunologically related to known viral protein
09/25/2001US6294173 Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein
09/25/2001US6294136 Image processing and analysis of individual nucleic acid molecules
09/25/2001US6294110 Color canceling marking systems
09/25/2001US6294094 Systems and methods for sensing red blood cell hematocrit
09/25/2001US6294062 Method and device for electrochemical immunoassay of multiple analytes
09/25/2001US6293847 Apparatus for chemical mechanical polishing endpoint detection using a hydrogen sensor
09/25/2001US6293152 Method for determining twist potential in wood
09/25/2001US6293137 Hydrogen sensor
09/25/2001CA2167048C Identification of ligands by selective amplification of cells transfected with receptors
09/25/2001CA2110058C Hepatitis c virus (hcv) polypeptides
09/24/2001CA2342089A1 Method of early prediction of the risk of paraffin dirt during production and transportation
09/20/2001WO2001069639A2 Method and apparatus for $m(f)i$m(g)in-vivo$m(f)/i$m(g) measurement of carbon monoxide production rate
09/20/2001WO2001069430A1 Database system and method
09/20/2001WO2001069413A2 Process for storing data
09/20/2001WO2001069403A1 On-site agricultural product analysis system and method of analyzing
09/20/2001WO2001069302A2 Fiber optic scanner
09/20/2001WO2001069262A1 ERβ-MEDIATED GENE EXPRESSION
09/20/2001WO2001069261A2 Proteins, genes and their use for diagnosis and treatment of vascular dementia
09/20/2001WO2001069260A2 A lysosomal pepstatin-insensitive proteinase as a novel biomarker for detecting and diagnosing breast cancer
09/20/2001WO2001069259A1 Method for detecting guanylyl cyclase and use thereof for diagnosing metastatic colorectal tumours
09/20/2001WO2001069258A1 Method for capturing analytes eluted from surface-bound ligands
09/20/2001WO2001069257A2 Device for in situ analysis and/or treatment with flexible rod
09/20/2001WO2001069256A2 Sensor element for optically detecting chemical or biochemical analytes
09/20/2001WO2001069255A2 Production, stabilisation and use of a novel type of chemically activated surfaces
09/20/2001WO2001069254A2 Visually detectable dye labelled biomolecules for analysis
09/20/2001WO2001069253A2 3d model of an fc epsilon receptor alpha chain-ige fc region complex
09/20/2001WO2001069251A2 Method for diagnosing immunologic food sensitivity
09/20/2001WO2001069250A1 Method for immuno-correcting therapy of preclinical and clinically expressed form of immunological inefficiency and method for rapid selection of a remedy for immuno-correction after guevodian
09/20/2001WO2001069248A2 An immunoassay diagnostic probe and its use
09/20/2001WO2001069247A2 Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells
09/20/2001WO2001069246A1 Test paper
09/20/2001WO2001069244A2 Method for labeling individual cells
09/20/2001WO2001069243A1 Measuring metabolic rate changes
09/20/2001WO2001069242A1 Blood analyzing method and apparatus
09/20/2001WO2001069241A2 Apparatus and method for high throughput electrorotation analysis
09/20/2001WO2001069240A1 Assay for agents that induce chemokinesis
09/20/2001WO2001069239A1 System and method for simulating cellular biochemical pathways
09/20/2001WO2001069238A2 Intestinal uptake of macromolecules
09/20/2001WO2001069237A1 Specimen having capability of separating solid component
09/20/2001WO2001069236A1 In situ monitor
09/20/2001WO2001069235A1 Simple method of biologically evaluating natural and artificial chemicals by using dna injury index and apparatus therefor
09/20/2001WO2001069234A1 Electronic device for detecting the conductance
09/20/2001WO2001069233A2 Sampling device for gas analyses of raw coke oven gases and other contaminated gases and method for analysis thereof
09/20/2001WO2001069232A1 Defect parameter for wooden members
09/20/2001WO2001069230A2 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
09/20/2001WO2001069229A2 Method for separating, identifying and quantifying alkaline isophosphatases by electrophoresis
09/20/2001WO2001069228A2 Mis hydrogen sensors
09/20/2001WO2001069227A2 Ion-sensitive microelectrodes
09/20/2001WO2001069213A2 Optical probes an methods for spectral analysis
09/20/2001WO2001069212A1 Device and method for in vitro detection of blood
09/20/2001WO2001069210A1 Device and method for detecting organic molecules in a test substance
09/20/2001WO2001069200A2 Methods for detection of differences in nucleic acids
09/20/2001WO2001069199A2 Methods of detecting cancer using cellular autofluorescence
09/20/2001WO2001069198A2 Assessing steels for undesirable phases
09/20/2001WO2001069191A1 Apparatus and method for measuring and correlating characteristics of fruit with visible/near infra-red spectrum
09/20/2001WO2001069186A1 Measuring and analyzing multi-dimensional sensory information for identification purposes
09/20/2001WO2001068923A2 Mitochondrial dosimeter
09/20/2001WO2001068922A1 High throughput screening by measurement of intracellular calcium levels
09/20/2001WO2001068915A1 Genotyping kit for diagnosis of human papillomavirus infection
09/20/2001WO2001068912A2 Diagnosis of diseases associated with tumor suppressor genes and oncogenes
09/20/2001WO2001068911A2 Diagnosis of diseases associated with the cell cycle
09/20/2001WO2001068909A1 Pcr-based identification of eimeria species and strains
09/20/2001WO2001068908A2 T2k kinase assays
09/20/2001WO2001068907A2 Stable expression of polymorphous forms of human cytochrome p450 2d6